Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Iron Supplementation in IPAH and Iron Deficiency
NCT01447628Phase 2Completed
- Sponsor
- Imperial College London
- Start
- Mar 2011
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of ferric carboxymaltose, iron dextran in pulmonary arterial hypertension (PAH), iron deficiency anemia (IDA), sponsored by Imperial College London. Started Mar 2011; status: completed.
02
Drugs
ferric carboxymaltoseiron dextran
03
Conditions
pulmonary arterial hypertension (PAH)iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT01447628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01447628.